Neoadjuvant immunotherapy for resectable esophageal cancer: A protocol of meta-analysis.

ABSTRACT:

Background

Esophageal cancer is a highly malignant cancer with a very poor prognosis. For resectable esophageal cancer, neoadjuvant treatment could improve the prognosis of esophageal cancer. However, current clinical neoadjuvant treatment options for esophageal cancer are still limited. The application of immunotherapy is a potentially beneficial new neoadjuvant treatment option for esophageal cancer. The objective of this meta-analysis is to evaluate the efficacy and safety of immunotherapy for the neoadjuvant treatment of esophageal cancer.

Methods

We will search Wanfang Database, SinoMed, China National Knowledge Infrastructure, Embase, Web of Science, Pubmed, and Cochrane Library for relevant articles published before July, 2021. We will also search the unpublished clin

SUBMITTER: Yu G 

PROVIDER: S-EPMC8177427 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature